Nordea Investment Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
SM
Nordea Investment Management's ALT Position: Q2 2019 in Review
Nordea Investment Management sold out of Altimmune (ALT) in Q2 2019, closing a stake of 3,700 shares — an estimated $11K sold.
Nordea Investment Management first reported a position in ALT in Q4 2018 and held it in 2 quarters. The position peaked at $11K in Q1 2019. 21 funds tracked by Wall St. Rank hold ALT as of Q2 2019.
- Nordea Investment Management reported no remaining Altimmune position as of Q2 2019 after selling out during the quarter.
- Nordea Investment Management sold 3,700 Altimmune shares in Q2 2019, an estimated $11K.
- Nordea Investment Management first reported a position in Altimmune in Q4 2018 and held it in 2 quarters.
- Nordea Investment Management's Altimmune position peaked at $11K in Q1 2019.
- 21 funds tracked by Wall St. Rank held Altimmune as of Q2 2019.
Based on Nordea Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.